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BACKGROUND
Depressive disorders are highly prevalent1,2 and have
a high incidence.3 They are also associated with huge
losses of quality of life in patients and their
relatives,4,5 increased mortality rates,6 high levels of
service use, and enormous economic costs.7–9 Major
depression is currently the fourth disorder worldwide
in terms of disease burden, and is expected to be the
disorder with the highest disease burden in high-
income countries by the year 2030.10
Most depressive disorders are treated in primary
care.11 Although many GPs tend to prescribe
antidepressant medications, the majority of patients
prefer psychological treatments.12 In the last few
decades, several randomised studies have examined
the effectiveness of psychological treatments in
primary care patients.13,14 Some of these found
positive effects,15–17 but several others found no
significant effects.18–20
It is important to assess the overall effectiveness of
treatments and to study possible determinants of
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ABSTRACT
Background
Although most depressive disorders are treated in
primary care and several studies have examined the
effects of psychological treatment in primary care,
hardly any meta-analytic research has been conducted
in which the results of these studies are integrated.
Aim
To integrate the results of randomised controlled trials
of psychological treatment of depression in adults in
primary care, and to compare these results to
psychological treatments in other settings.
Design of study
A meta-analysis of studies examining the effects of
psychological treatments of adult depression in
primary care.
Setting
Primary care.
Method
An existing database of studies on psychological
treatments of adult depression that was built on
systematic searches in PubMed, PsychINFO, EMBASE,
and Dissertation Abstracts International was used.
Randomised trials were included in which the effects of
psychological treatments on adult primary care
patients with depression were compared to a control
condition.
Results
In the 15 included studies, the standardised mean
effect size of psychological treatment versus control
groups was 0.31 (95% CI = 0.17 to 0.45), which
corresponds with a numbers-needed-to-treat (NNT) of
5.75. Studies in which patients were referred by their
GP for treatment had significantly higher effect sizes
(d = 0.43; NNT = 4.20) than studies in which patients
were recruited through systematic screening (d = 0.13,
not significantly different from zero; NNT = 13.51).
Conclusions
Although the number of studies was relatively low and
the quality varied, psychological treatment of
depression was found to be effective in primary care,
especially when GPs refer patients with depression for
treatment.
Keywords
cognitive behaviour therapy; depression; major
depression; meta-analysis; psychological treatment;
psychotherapy.
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treatment outcome, as psychological treatments for
depression are widely applied in primary care.
Patients enrolled in primary care generally have a
less progressed developmental stage of their illness
than patients in specialised healthcare settings,21,22
and this may be related to the effectiveness of
psychological treatments. However, only one earlier
meta-analysis has integrated the results of studies
on psychological treatments of depression in primary
care.23 Although this meta-analysis found evidence
that psychological treatments are effective in primary
care, it has several limitations. It included only a
limited number of the currently available studies and
did not conduct elaborate subgroup analyses to
examine the heterogeneity of outcomes.
Furthermore, by focusing only on studies in primary
care, it does not answer the question whether these
treatments are less effective than in other settings, as
has been suggested in the literature.24 Therefore, the
aim of the present systematic review is to conduct a
meta-analysis of randomised studies examining
psychological treatments in primary care patients.
Several of these studies found small or even
negative effects for these treatments, which led to
suggestions that psychological treatments are less
effective in primary care than in other settings.24 As a
consequence, multivariate meta-regression
techniques were used on a large database of
randomised controlled studies of psychological
treatments of depression to examine whether these
treatments are less effective when delivered in
primary care as compared to other settings.
METHOD
Identification and selection of studies
A large database of studies of the psychological
treatment of depression in general was used. This
database, how it was developed, and the methods
used have been described in detail elsewhere.25 Key
materials, overviews of the goals and mission, and an
overview of all other published meta-analyses that
have used this database can be downloaded from the
website for this project (www.psychotherapyrcts.org).
In brief, the database was developed through a
comprehensive literature search (from 1966 to
December 2007) in which 8861 abstracts in PubMed
(1403 abstracts), PsycINFO (2097), EMBASE (2207),
and the Cochrane Central Register of Controlled
Trials (2204) were examined. Moreover, the
Dissertation Abstracts International (950 abstracts)
was examined to identify unpublished studies. These
abstracts were identified by combining terms
indicative of psychological treatment and depression
(both MeSH terms and text words). In addition, the
primary studies from 22 meta-analyses of
psychological treatment of depression26 were
collected and the references of included studies
were examined. A total of 857 published papers and
33 dissertations were retrieved for further study
(Figure 1).
The abstracts from the bibliographic databases
were screened and the retrieved reports were
examined independently by two reviewers for
possible inclusion. When the two reviewers
disagreed, they discussed the differences with the
third reviewer until agreement was reached.
This meta-analysis included: (a) randomised
controlled trials (b) that examined adult primary care
patients (c) with a depressive disorder or an elevated
level of depressive symptomatology (d) in which the
effects of a psychological treatment (e) delivered in
primary care (f) was compared to a control condition.
Primary care patients had been recruited through
direct referrals from GPs, or through systematic
screening of patients waiting to see their GP or who
had recently been seen by the doctor.
The same inclusion criteria were used for the
meta-regression analysis, in which psychological
treatment in primary care was compared with other
settings, except that all studies on any adult patient
group were included.
Psychological treatments were defined as
interventions in which verbal communication
between a therapist and a client was the core
element, or in which a psychological treatment was
written down in book format or a computer program
(guided self-help or bibliotherapy) that the client
worked through more or less independently, but with
some kind of personal support from a therapist (by
telephone, email, or otherwise). The following
studies were excluded: studies on children and
adolescents (<18 years of age); studies in which the
psychological intervention could not be discerned
from other elements of the intervention (managed
care interventions and disease management
programmes); studies in which a standardised effect
size could not be calculated (mostly because no test
was performed in which the difference between the
experimental and the control groups was examined);
studies on inpatients; studies focusing on
maintenance treatments and relapse prevention;
and studies that included participants who were
either anxious or depressed (studies with patients
How this fits in
Psychological treatment of depression is effective in primary care patients. This
meta-analysis found no indication that psychological treatments of depression
are less effective in primary care than in other settings, as long as the patients
are referred by their GP. Studies in which patients were recruited through
systematic screening seem to result in lower effect sizes.
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who were both anxious and depressed were
included). Comorbid general medical or psychiatric
disorders were not used as an exclusion criterion.
No language restrictions were applied.
Data extraction
Studies were coded on three domains. First to be
coded were several patient characteristics: target
population (adults, older adults, specific
population, such as women with postnatal
depression, people with general medical disorders,
and minority groups); recruitment method (open
community recruitment, recruitment from clinical
samples, recruitment in primary care, recruitment
through systematic screening not in primary care,
and other recruitment method); definition of
depression (major depressive disorder diagnosed
with a formal diagnostic interview such as the
Composite International Diagnostic Interview or the
Structural Clinical Interview, other definition of
depression, usually depression defined as scoring
above a cut-off score on a self-report scale, or
depressive disorders including dysthymia, minor
depression, or adjustment disorders). The severity
of depression at baseline was investigated by
examining the score on the Beck Depression
Inventory (BDI)27 at pre-test, as well as the score on
the Hamilton Rating Scale for Depression (HAM-
D),28 although these data were only available for a
limited number of studies.
Second to be coded were characteristics of the
intervention (cognitive behaviour therapy, problem-
solving therapy, and other therapies); format of the
therapy (individual, group, and guided self-help);
number of treatment sessions (≤6 or ≥7). The
professional background of the therapists (Table 1)
was also coded, but was not examined further
because of the wide diversity of these professional
backgrounds.
Third to be coded were general characteristics of
the design of the studies: type of control group
(waiting list, care-as-usual, and other control group);
type of analyses (intention-to-treat analyses, and
completers-only analyses); and country (US, UK,
and other).
Quality assessment
The validity of the studies was assessed using
three basic criteria:29 allocation to conditions was
done by an independent (third) party; blinding of
assessors of outcomes; and completeness of
follow-up data. A fourth basic criterion (blinding of
participants about the condition they were
assigned to) was not used, because this is usually
not possible in studies examining psychological
treatments.
Analyses
Effect sizes (standardised mean difference, d) were
calculated for each study by subtracting (at post-test)
the average score of the control group from the
average score of the experimental group and dividing
the result by the pooled standard deviations (SDs) of
the experimental and control groups. Thus, an effect
size of 0.5 indicates that the mean of the experimental
group is half an SD larger than the mean of the control
group. Effect sizes of 0.80 and higher can be
assumed to be large, while effect sizes of 0.50 to 0.80
are moderate, and lower effect sizes are considered
to be small.30
Only those instruments that explicitly measure
symptoms of depression were used in the calculations
of effect sizes (Table 1). If more than one measurement
of depression had been used, the mean of the effect
sizes was calculated, so that each study (or contrast
group) only contributed one effect size. When means
and SDs were not reported, other statistics (t-value, P-
value) were used to calculate effect sizes.
The standardised mean difference is not easy to
interpret from a clinical point of view and so the
numbers-needed-to-treat (NNT) were also calculated,
using the formulae provided by Kraemer.31 The NNT is
defined as the number of patients one would expect
to treat with a psychological treatment to have one
more successful outcome compared to the same
number of patients in the control group.
The Comprehensive Meta-analysis computer
program (version 2.2.021), which was developed for
support in meta-analysis, was used to calculate
pooled mean effect sizes, and the random effects
model29 was used to conduct all analyses because
considerable heterogeneity was expected.
The Q statistic was calculated as an indicator of
heterogeneity. The I2 statistic, which is an indicator of
heterogeneity in percentages, was also calculated. A
value of 0% indicates no observed heterogeneity, and
larger values show increasing heterogeneity, with 25%
as low, 50% as moderate, and 75% as high
heterogeneity.32
Publication bias was tested by inspecting the
funnel plot of the meta-analysis, and by using Duval
and Tweedie’s trim and fill procedure,33 which yields
an estimate of the effect size after publication bias
has been taken into account. This procedure is
based on the expectation that if no publication bias
is present the effect sizes will be dispersed equally
on either side of the overall effect. An asymmetric
funnel plot can be seen as an indication for
publication bias (if there is a relatively large number
of small studies falling towards the right of the mean
effect and relatively few falling towards the left).
Duval and Tweedie developed a method that allows
imputation of missing studies. This method
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determines where the missing studies are likely to
fall, adds them to the analysis, and then recomputes
the combined effect.
Subgroup analyses and univariate meta-regression
analyses were conducted according to the procedures
implemented in Comprehensive Meta-analysis
(version 2.2.021). The subgroup-analyses used mixed-
effects analyses that pooled studies within subgroups
with the random effects model, but tested for
significant differences between subgroups with the
fixed effects model.
Multivariate meta-regression analyses in which
more than one predictor was entered simultaneously
were conducted in STATA/SE (8.2 for Windows),
because these analyses cannot be conducted in
Comprehensive Meta-analysis. To avoid collinearity
among the predictors that were entered in the
regression models, it was examined whether high
correlations were found among the variables that
could be entered into the model. The correlations
between all variables described in the ‘Data
extraction’ section above were calculated and it was
checked whether the correlations were lower than
r = 0.60.
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Definition of Psychological Sessions Treatment
Study Recruitment depression treatment n n Format provider Control n Measurements Instruments ITT Country
Barrett NR DYS or minD + PST 80 6 Ind Psychol Placebo 81 Pre, post HSCL-D-20 + US
et al, 200118 HAM-D >10
Conradi Referral MDD (CIDI) CBT (+PE) 44 14 Ind Psychol CAU 72 Pre, post, BDI + NL
et al, 200734 3, 6, 36 mo
King et al, Referral BDI >14 + CBT 63 6 Ind Psychol CAU 67 Pre, post, BDI + UK
200035 depressed Non-directive 67 Psychol 12 mo
according to GP counseling
Lynch et al, Screening HAM-D 11–26, PST Stress 9 6, t Ind Nurse CAU 13 Pre, Post BDI, DHP-D − US
200419 management 18 6, t Nurse
Lynch et al, Screening sD (High MOS-DSI; PST 11 6 Ind Students CAU 13 Pre, Post HAM-D, − US
199736 no MDD/DYS) BDI
Mynors-Wallis Referral MDD (RDC) + PST 30 6 Ind Psychiatr + Placebo 30 Pre, post HAM-D, BDI + UK
et al, 199515 HAM-D >13 GPs
Ross & Scott, Referral MDD (PSE/ CBT (Ind) 21 12 Ind Social worker WL 21 Pre, post, BDI, MADRS − UK
198516 RDC) + BDI >15 CBT (group) 9 12 Grp Social worker 3, 6, 12 mo
Schulberg Screening MDD (DIS/DSM- IPT 93 16 Ind Psychiatr + CAU 92 Pre, post, HAM-D + US
et al, 199617 III-R) + HAM-D >13 psychol 2, 4 mo
Scott & Referral MDD (DSM-III) CBT 29 16 Ind Psychol CAU 29 Pre, post HAM-D − UK
Freeman, 199238 Counseling 29 16 Ind Social workers
Scott et al, Referral MDD (DSM-III-R) CBT 18 6 Ind CBT therapist CAU 16 Pre, post, HAM-D, BDI − UK
199739 + BDI >20 3, 6, 12 mo
Scott & Referral Depressive disorder CBT (ind) 27 12 Ind NR WL 23 Pre, post, BDI, MADRS, − UK
Stradling, (RDC/PSE) CBT (grp) 17 12 Grp NR 3, 6, 12 mo IDAQ
199037 + BDI >14
Simpson Screening BDI 14–40, Psychodynamic 73 6–12 Ind Counsellors CAU 72 Pre, post, BDI + UK
et al, 200320 depressed counseling 12 mo
for 6 months
Teasdale et al, NR MDD (RDC) + BDI CBT 17 15 Ind Psychol CAU 17 Pre, post, MADRS, + UK
198440 >20 + HAM-D >14 3 mo BDI, HAM-D
Van Schaik Screening GDS-15 >5 + IPT 69 10 Ind Psycholog + CAU 74 Pre, post MADRS, GDS + NL
et al, 200624 MDD (Prime-MD) psychiatr nurses
Williams Screening DYS or minD PST 80 6 Ind Psycholog + social Placebo 81 Pre, Post HSCL-D-20 + US
et al, 200041 + HAM-D >10 workers + counselors
BDI = Beck Depression Inventory. CAU = care-as-usual. CBT = cognitive-behavioural therapy. CIDI = Composite International Diagnostic Interview. DHP-D = Duke
Health Profile – depression scale. DIS = Diagnostic Interview Schedule. DSM-III-R = The Diagnostic and Statistical Manual of Mental Disorders – third revision. DYS
= dysthymia. GDS = Geriatric Depression Scale. Grp = group therapy. HAM-D = Hamilton Rating Scale for Depression. HSCL-D-20 = Hopkins Symptom Checklist
Depression Scale. IDAQ = Irritability, Depression, Anxiety Questionnaire. Ind = individual therapy. IPT = interpersonal psychotherapy. ITT = intention-to-treat.
MADRS = Montgomery-Åsberg Depression Rating Scale. MDD = major depressive disorder. minD = minor depression. Mo = months. MOS-DSI = Medical
Outcomes Study – Depression Sscreening Iinventory. NL = the Netherlands. NR = not reported. PE = psycho-education. Prime-MD = The Primary Care
Evaluation of Mental Disorders. PSE = Present State Examination. PST = problem-solving therapy. psychiatr nurse = psychiatric nurse. Psychiatr = psychiatrist.
Psychol = psychologist. RDC = Research Diagnostic Criteria. sD = subthreshold depression. t = telephone sessions. WL = waiting-list control group.
Table 1. Selected characteristics of randomised controlled studies examining psychological treatment in
primary care.
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RESULTS
Description of included studies
All inclusion criteria for studies on psychological
treatment in primary care were met by 15 studies, in
which 20 psychological treatment conditions were
compared to a control group.15–21,34–41 In these 15
studies, a total of 1505 patients participated (804 in
the psychological treatment conditions and 701 in the
control conditions). Selected characteristics of the
studies included are presented in Table 1. A flow chart
of the inclusion of studies and the reasons for
exclusion are presented in Figure 1.
Patients in seven studies were referred to the study
by the GP, while in six other studies patients were
screened for depression (while waiting for their GP, or
by a postal questionnaire sent to patients who had
recently been seen by their GP). Mixed methods were
used in the remaining two studies, or the recruitment
method was not clear. Other characteristics of the
studies and the comparisons between
psychotherapies and control conditions can be found
in Table 2 (diagnosis; type of psychotherapy; number
of sessions; type of control group, intention-to-treat
analyses, and country where the study was
conducted).
The pre-test scores on the BDI were available in
eight studies (11 comparisons). In 10 of these 11
comparisons the pre-test BDI scores fell inside the
range of moderate to severe depression (BDI
between 19 and 29), while the mean BDI score was
in the severe range at pre-test in only one of the
studies. The pre-test score on the HAM-D was
available in seven studies (eight comparisons) and
ranged from 13.3 to 22.3 (six comparisons below 20
and two above).
The quality of the studies varied. Blinding of
assessors was reported in 13 studies and eight
studies reported that allocation to conditions had
been conducted by an independent party. Drop-out
numbers ranged from 3.3% to 41.2% (one study did
not report drop-out). Intention-to-treat analyses were
conducted in 10 studies and all patients who were
randomised were used in these analyses, whether or
not they dropped out of the intervention or study; the
other studies were limited to completers-only
analyses.
Psychological treatment in primary care versus
control at post-test
The overall mean effect size of psychological
treatment versus the control conditions at post-test
was 0.31 (95% CI = 0.17 to 0.45), which is usually
considered to be a small effect.30 Heterogeneity was
significant (Q = 34.91; P<0.05), but low to moderate
(I2 = 45.58). The NNT which corresponds to an effect
size of 0.31 was 5.75. Details of these results are
shown in Table 2 and Figure 2.
The analyses included studies in which more than
two psychological treatments were compared to a
control group, which means that multiple
comparisons from one study were included in the
same analysis. These multiple comparisons are not
independent of each other, which may have resulted
in an artificial reduction of heterogeneity and a bias in
the overall mean effect size. Additional analyses were
conducted as a consequence, in which only one
comparison per study was included (Table 2). Only
the comparison with the largest effect size was
included first, followed by another analysis including
only the smallest effect size. Table 2 shows that the
results did not differ very much from those in which all
comparisons were included.
Comparable effect sizes were found (d = 0.43; 95%
CI = 0.22 to 0.64; Q = 26.30, not significant; I2 = 50.57;
n = 14) when the analyses were limited to the effect
sizes found for the BDI. The result was the same
when the analyses were limited to the effect sizes
found for the HAM-D, which is a clinical interview (d =
0.49; 95% CI = 0.30 to 0.68; n = 7); however,
heterogeneity was zero in these analyses (Q = 5.34;
not significant; I2 = 0).
Neither the funnel plots nor Duval and Tweedie’s
trim and fill procedure indicated a significant
publication bias. The effect size decreased somewhat
after adjustment for possible publication bias
(adjusted effect size: d = 0.20; 95% CI = 0.05 to 0.34),
but the observed and adjusted effect size did not
differ significantly.
The effects of psychological treatments at follow-
up were not examined. No effect sizes were available
at follow-up in nine studies (either because no
P Cuijpers, A van Straten, A van Schaik and G Andersson
123 randomly allocated8861 references identified by 
literature search:
PubMed: 1403
PsycINFO: 2097
Embase: 2207
Cochrane: 2204
Dissertations: 950
890 publications retrieved
(including 33 dissertations)
115 controlled studies of
psychotherapy
15 controlled studies of
psychotherapy in
primary care
Excluded:
Studies with adolescents (66)
No random assignment (48)
Duplicate publication (212)
Not only depression (96)
No psychotherapy (108)
No control condition (158)
Maintenance trial (32)
Figure 1. Flowchart of
inclusion of studies.
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follow-up assessment took place, or because a
waiting list control group was used and this control
group had received treatment at follow-up). The
attrition rate was higher than 50% in one of the
remaining six studies,39 while the follow-up periods
ranged from 3 to 36 months in the other five studies.
Because of the small number of studies and the large
differences in follow-up periods, the results of the
treatments at follow-up were not pooled.
Subgroup analyses
Several subgroup analyses were conducted, using the
characteristics of the studies as described in the
above section on ‘Data extraction’, except that
subgroup analyses were not conducted with the target
population, because all studies focused on adults in
general. In addition, recruitment method (community
recruitment, recruitment from clinical samples, and
other recruitment methods) was not examined in these
subgroup analyses, because patients in all these
studies were recruited through primary care. The
results of the subgroup analyses are presented in
Table 2.
The studies in which patients were recruited through
systematic screening resulted in a significantly lower
effect size (d = 0.13; 95% CI = –0.08 to 0.34; Q = 9.82,
not significant; I2 = 38.89) than studies in which
patients were referred directly by the GP (d = 0.43;
95% CI = 0.28 to 0.58; Q = 9.71, not significant; I2 = 0).
The effect size for the studies in which patients were
recruited through systematic screening was not
significantly different from zero. There was a
significant association (P<0.05) between effect size
and the country where the study was conducted.
Studies in the UK found a higher mean effect size (d =
0.45; 95% CI = 0.28 to 0.62) than studies in the US (d
= 0.11; 95% CI = –0.15 to 0.38) and the two studies in
the Netherlands (d = 0.10; 95% CI = –0.15 to 0.35);
heterogeneity was low to moderate in the three
subgroups, and the results of the studies in the US
e56
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nstudies ncomp d 95% CI Z Q I2 P-valueg NNT
All studies 20 20 0.31 0.17 to 0.45 4.25d 34.91b 45.58 5.75
One effect per study (highest) 15 15 0.30 0.13 to 0.48 3.47c 30.35c 53.88 5.95
One effect per study (lowest) 15 15 0.25 0.09 to 0.41 3.10c 27.08b 48.30 7.14
BDI only 10 14 0.43 0.22 to 0.64 4.07d 26.30b 50.57 4.20
HAM-D only 7 7 0.49 0.30 to 0.68 5.11d 5.34, ns 0 3.68
Subgroup analyses
Recruitmentf
Referral 7 11 0.43 0.28 to 0.58 5.75d 9.71, ns 0 b 4.20
Screening 6 7 0.13 –0.08 to 0.34 1.23 9.82, ns 38.89 13.51
Diagnosis
MDD 7 10 0.21 –0.00 to 0.42 1.95e 19.15b 53.00 ns 8.47
Other 7 10 0.40 0.23 to 0.56 4.61d 11.12, ns 19.09 4.50
Type of treatmenth
CBT 7 9 0.42 0.22 to 0.62 4.16d 9.72, ns 17.67 ns 4.27
PST 5 5 0.19 –0.15 to 0.53 1.08, ns 9.77b 59.05 9.43
Other 5 6 0.27 0.04 to 0.49 2.35b 9.65e 48.20 6.58
Number of sessionsh
≤6 7 9 0.25 0.02 to 0.48 2.12b 16.56b 51.68 ns 7.14
≥7 8 11 0.36 0.17 to 0.54 3.75d 17.34e 42.34 5.00
Control group
Care-as-usual 10 13 0.29 0.14 to 0.43 3.87d 15.88, ns 24.45 ns 6.17
Other 5 7 0.40 0.07 to 0.73 2.39b 18.73c 67.97 4.50
Analyses
Intention-to-treat 10 10 0.23 0.05 to 0.42 2.47b 23.18c 61.18 e 7.69
Completers-only 5 10 0.47 0.27 to 0.68 4.48d 6.53, ns 0 3.85
Country
UK 8 12 0.45 0.28 to 0.62 5.19d 15.09, ns 27.09 b 4.00
US 5 6 0.11 –0.15 to 0.38 0.84, ns 10.01e 50.03 16.13
NL 2 2 0.10 –0.15 to 0.35 0.81, ns 0.50, ns 0 17.86
aAccording to the random effects model. bP<0.05. cP<0.01. dP<0.001. eP<0.1. fIn two studies information about how patients were screened was insufficient.
gThe P-value indicates whether the difference between subgroups is significant. hThe total number of studies is larger than 15 because some studies examined
more than one type of psychotherapy. ncomp = number of comparisons. d = standardised mean difference. Q = indicator of homogeneity. I
2 = indicator of
heterogeneity in percentages. NNT = numbers-needed-to-treat. BDI = Beck Depression Inventory. HAM-D = Hamilton Rating Scale for Depression. MDD = major
depressive disorder. CBT = cognitive behavioural therapy. PST = problem solving therapy. NL = the Netherlands.
Table 2. Meta-analyses of studies examining effects of psychological treatment of depression in primary
care compared to control conditions at post-test: overall results and subgroup analyses.a
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and the Netherlands were not significantly different
from zero. There was a trend (P<0.1) indicating that
studies using intention-to-treat analyses resulted in
lower effect sizes (d = 0.23; 95% CI = 0.05 to 0.42)
than studies using completers-only analyses (d =
0.47; 95% CI = 0.27 to 0.68).
Most BDI and HAM-D scores at pre-test were in the
same range of severity (moderate to severe), which
meant it was not possible to examine whether severity
at pre-test was related to the effect size.
Psychological treatment in primary care versus
other settings
The effect sizes found for psychological treatments in
primary care were relatively small compared to the
results of psychological treatments for depression in
general42,43 and, therefore, treatments delivered in
primary care were compared directly with these
treatments when conducted in other settings (such as
in samples recruited through media announcements,
or in clinical samples from specialised mental health
care). A literature search identified 99 studies in which
psychological treatments in other outpatient settings
than primary care were compared to a control
condition. These 99 studies included a total of 154
comparisons between a psychological treatment and
a control group; 6427 patients with depression
participated in these studies: 3843 in the
experimental groups and 2584 in the control groups.
Patients in 55 of the 99 studies (55.6%) were recruited
from the community; patients in nine studies (9.1%)
were recruited from specialised mental health
services; patients in 18 (18.2%) studies were
recruited through systematic screening (not in
primary care, but in community or general medical
samples); and 17 studies (17.2%) used other
recruitment methods. Other selected characteristics
of the 154 comparisons can be found on the website
of this project (www.psychotherapyrcts.org).
The effects of the psychological treatments in
primary care (d = 0.31; 95% CI = 0.17 to 0.45) were
compared with those in other settings (d = 0.67; 95%
CI = 0.58 to 0.75), and it was found that this
difference was highly significant (P<0.001). Results
of these analyses are presented in Table 3. Very high
effect sizes (d>2.0) were found in some studies
(conducted in settings other than primary care) and
the possibility that these could be outliers led to
another analysis from which these potential outliers
were excluded. The difference between studies in
primary care and those in other settings remained
highly significant (P<0.001) in these analyses. This
difference was also highly significant when only one
effect size per study was used and when the
analyses were limited to effect sizes based on the
HAM-D and the BDI (Table 3).
Multivariate meta-regression analyses
Studies in primary carea Studies in other settings
n d 95% CI NNT n d 95% CI Z Q I2 NNT P-value
All studies 20 0.31 0.17 to 0.45 5.75 154 0.75 0.65 to 0.84 15.49 519.52 70.55 2.48 <0.001
Outliers excluded 20 0.31 0.17 to 0.45 5.75 146 0.67 0.58 to 0.75 15.34 388.29 62.66 2.75 <0.001
One effect size per study (highest) 15 0.30 0.13 to 0.48 5.95 99 0.79 0.67 to 0.91 12.59 386.57 74.65 2.36 <0.001
One effect size per study (lowest) 15 0.25 0.09 to 0.41 7.14 99 0.62 0.51 to 0.73 11.38 297.08 67.01 2.96 <0.001
BDI only 14 0.43 0.22 to 0.64 4.20 98 0.80 0.68 to 0.92 12.96 288.16 66.34 2.34 <0.01
HAM-D only 7 0.49 0.30 to 0.68 3.68 50 0.97 0.79 to 1.15 10.77 149.85 67.30 1.97 <0.001
aMore details about these effect sizes can be found in Table 2. BDI = Beck Depression Inventory. d = standardised mean difference. HAM-D = Hamilton Rating
Scale for Depression. I2 = indicator of heterogeneity in percentages. NNT = numbers-needed-to-treat. Q = indicator of homogeneity.
Table 3. A meta-analytic comparison of psychological treatment of depression in primary care and other
settings
Study name Statistics for each study
Std diff  Lower Upper  P-value 
 in means limit limit
Barrett, 2001 –0.07 –0.38 0.24 0.66
Conradi, 2007 0.00 –0.38 0.38 1.00
King, 2000 A 0.34 –0.01 0.69 0.05
King, 200 B 0.49 0.15 0.83 0.01
Lynch, 2004 A 0.09 –0.76 0.94 0.84
Lynch, 2004 B –0.28 –1.13 0.57 0.52
Lynch, 1997 0.63 –0.19 1.45 0.13
Mynors-Williams, 1995 0.74 0.22 1.26 0.01
Ross, 1985 A 0.66 –0.14 1.46 0.11
Ross, 1985 B 0.66 0.04 1.28 0.04
Schulberg, 1996 0.44 0.15 0.73 0.00
Scott, 1992 A 0.25 –0.27 0.77 0.34
Scott, 1992 B 0.53 0.01 1.05 0.05
Scott, 1997 0.49 –0.19 1.17 0.16
Scott, 1990 A 0.84 0.19 1.49 0.01
Scott, 1990 B 0.56 –0.01 1.13 0.05
Simpson, 2003 –0.06 –0.39 0.27 0.72
Teasdale, 1984 0.87 0.17 1.57 0.02
Van Schaik, 2006 0.18 –0.15 0.51 0.28
Williams, 2000 –0.08 –0.39 0.23 0.61
0.31 0.17 0.45 0.00
–2.00 –1.00 0.00 1.00 2.00
 Favours control Favours therapy
Std diff in means and 95% CI
Figure 2. Standardised
effect sizes of psychological
treatment of depression in
primary care patients
compared to control
conditions at
post-test (A and B indicate
two treatments from one
study that were compared
to a control group).
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As the significant difference between studies in
primary care and those in other settings could have
been influenced by characteristics of the populations,
the interventions, and the design of the studies,
multivariate meta-regression analyses were
conducted which controlled for these variables.
For the purposes of the first meta-regression
analysis (with the effect size as the dependent
variable), all characteristics described in the above
‘Data extraction’ section were entered as predictors,
after transforming them into dummy variables.
Recruitment through primary care was one of the
predictors in these analyses, the results of which are
presented in Table 4, and it is clear that recruitment in
primary care was a significant predictor of the effect
size, even after controlling for all other characteristics
of the studies (B = –0.41; standard error [SE] = 0.19; P
= 0.03).
Indications that there were two types of
recruitment in primary care resulted in the same
meta-regression analysis being conducted once
more (with the same predictors), but this time two
separate dummy variables were entered for
recruitment in primary care: the first one indicated
referral by the GP to the treatment, and the second
one indicated systematic screening of primary care
patients. Results of these analyses are presented in
Table 4 and show that referral by the GP was not a
significant predictor (P = 0.38), but systematic
screening was (B = –0.60; SE = 0.23; P = 0.01).
DISCUSSION
Summary of main findings
The psychological treatment of depression is
effective in primary care patients. Although the
effects seemed to be lower than the effect sizes
found for psychological treatments in other settings,
these findings suggest that the studies in which
patients from primary care populations were
screened systematically were responsible for this
lower effect size. When patients are referred by their
GP for psychological treatment, no indication that
the effects are lower than the effect sizes found for
psychological treatment of depression in other
settings was found. Earlier systematic reviews found
indications that screening for depression in
healthcare settings results in positive outcomes.44
However, in the current study no evidence was
found that psychological treatment is effective if
patients are recruited through systematic screening
in primary care, although this finding should be
considered with caution because of the limitations
of this study.
Strengths and limitations of the study
This study has several limitations. First of all, the
number of studies in primary care was relatively low,
and the quality of the studies included was not
optimal. Secondly, there were several important
differences between these studies and the influence
of these differences on the outcomes is not clear.
Thirdly, there was considerable heterogeneity in most
analyses, which suggests that the effects of therapies
may be associated with, and perhaps confounded by,
characteristics other than those examined in the
subgroup analyses. A fourth limitation is that meta-
regression techniques are known to have several
limitations,45,46 and their results should be considered
with caution. Another important limitation is that
many of the included studies compared
psychological treatments with usual care. The
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Full model (with screening and
Full model referral as separate predictors)a
Variable ncomp B SE P-value B SE P-value
Recruitment method
Community 96 Ref Ref
Primary Care 20 –0.41 0.19 0.03 Screeninga –0.60 0.23 0.01
Referrala –0.21 0.24 0.38
Screeningb 26 –0.11 0.17 0.53 –0.03 0.19 0.88
Clinical 13 –0.02 0.19 0.93 –0.10 0.17 0.57
Other 19 –0.03 0.16 0.86 –0.05 0.16 0.38
Target group
Adults 95 Ref Ref
Older adults 21 –0.10 0.14 0.47 –0.07 0.14 0.61
Specific population 58 0.08 0.12 0.50 0.09 0.12 0.47
Diagnosed MDD (y/n) 43 0.14 0.11 0.20 0.12 0.11 0.29
Type of treatment
Other treatment 75 Ref Ref
CBT 85 0.02 0.10 0.84 0.00 0.10 0.99
PST 14 0.28 0.18 0.11 0.34 0.18 0.06
Treatment formal
Individual 87 Ref Ref
Group 68 –0.18 0.10 0.09 –0.19 0.10 0.06
Guided self-help 18 –0.14 0.18 0.45 –0.13 0.18 0.46
Number of sessions 56 –0.14 0.11 0.22 –0.11 0.11 0.32
(<6 vs ≥7)
Control group
Waiting list 97 Ref Ref
Care-as-usual 53 –0.38 0.13 0.004 –0.34 0.13 0.01
Other 24 –0.62 0.14 <0.001 –0.61 0.14 <0.001
Intention to treat 52 –0.06 0.11 0.58 –0.04 0.11 0.70
analyses (y/n)
Country
US 104 Ref Ref
UK 22 0.02 0.17 0.91 –0.09 0.18 0.60
Other 48 0.29 0.11 0.01 0.27 0.11 0.02
Constant 174 1.04 0.15 <0.001 1.03 0.15 <0.001
aIn this model the studies in primary were divided into those in which patients were
recruited through systematic screening and those in which patients were referred.
bSystematic screening in populations, not in primary care. CBT = cognitive-behavioural
therapy. MDD = major depressive disorder. ncomp = number of comparisons. PST = problem-
solving therapy.
Table 4. Regression coefficients of study characteristics in
relation to the effect size of psychological interventions for
depression: multivariate meta-regression analyses with
recruitment in primary care as predictor.
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content of the ‘usual care’ arm in trials is crucial to
interpreting the outcome of studies, but is often
poorly described, not only in the papers reviewed, but
also in other research fields.47 However, usual care
varies widely48 and this may have distorted the results
of the meta-analysis.
Comparison with existing literature
It is not clear why the effect sizes are so small when
patients are recruited through systematic
screening. Patients who do not actively seek
treatment may have good reasons why they have
not actively sought treatment before. One
possibility is that their depression is less severe
than patients in specialised mental health care and
that the motivation to accept treatment is less
strong. It is also possible that they think treatment
will not be effective in their situation or expect their
problems will disappear spontaneously. Another
possibility is that those identified by screening are
less severely or persistently depressed, and the
screening instruments may not be subtle enough to
detect such differences. Moreover, the possibility
cannot be excluded that GPs inform and motivate
patients to accept the offer of psychological
treatment, whereas this happens to a much lesser
extent in settings in which treatment
recommendations follow a systematic screening
procedure. Also, GPs implicitly use several other
indicators to assess whether a patient will benefit
from psychotherapy, such as former experience
with psychotherapy of the patient, the physician’s
own experience with the patient in commitment
with proposed treatments, and the role of specific
temporary life events or somatic diseases that may
resolve spontaneously. More research is needed to
explore this finding.
Implications for future research and clinical
practice
This study has several implications. First, GPs who
refer to treatments and the treatment providers might
need to collaborate closely as the right referral route
appears to make a difference. Second, while
screening tools may identify cases of depression, they
might not screen effectively for suitability for
psychological treatment. This could require that
screening tools for suitability for psychological
treatments should be developed.
Despite the limitations of this study, the results
clearly suggest that psychological treatment is
effective in primary care, but only when the patients
with depression are referred by their GP for treatment.
Systematic screening for patients with depression in
primary care does not appear to lead to beneficial
outcomes following psychological treatments.
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